Activiomics, Kyowa Hakko Kirin deal

Activiomics extended a 2012 deal with Kyowa under which Activiomics is using its Targeted In-depth Quantification of Cell Signaling (TIQUAS) phosphoproteomics platform to identify signaling mechanisms...